Statin treatment for Moyamoya disease study
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests if statins (cholesterol-lowering drugs) can help people with Moyamoya disease. The trial will follow patients who receive either surgery or standard care to see if adding a statin improves outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You have been diagnosed with Moyamoya disease by imaging.
- Your disability level is mild (mRS score of 0–2).
- You are receiving either revascularization surgery or conservative care.
- You have at least one follow-up imaging scan available.
- You cannot have certain other conditions (like atherosclerosis, autoimmune disease, or prior stroke over 3 months before diagnosis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial follows people with moyamoya disease who are treated with medication only, and it also looks at first-degree relatives. The goal is to understand long-term outcomes and whether careful conservative care is beneficial over time.
This study looks at how Moyamoya disease changes over time and what predicts outcomes. It uses approved brain imaging and, likely, thinking/memory tests to understand prognosis.
This study tests whether daily aspirin, a special physical therapy called remote ischemic conditioning (RIC), or both can slow down moyamoya disease, a condition that narrows brain blood vessels and increases stroke risk. Participating may help you manage your condition and possibly prevent it from getting worse.
This study looks at why some people with moyamoya disease have trouble with thinking and memory. It may help find better ways to understand and treat these problems.
This study investigates moyamoya disease, a rare condition where blood vessels in the brain narrow over time. Researchers want to identify genetic and early warning signs by studying people diagnosed with the disease, their blood relatives, and healthy volunteers.
This study uses advanced MRI scans to better predict the risk of bleeding in people with moyamoya disease, a rare condition where brain arteries narrow. It aims to improve prevention of bleeding strokes.
Hear when a new Moyamoya Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.